Phathom Pharmaceuticals (PHAT) EBT Margin (2023 - 2026)
Phathom Pharmaceuticals' EBT Margin came in at -23.64% for Q2 2026, up 167.88 percentage points from -191.52% a year earlier and up 27.03 percentage points from the prior quarter.
Powered by 
Analysis
Phathom Pharmaceuticals (PHAT) EBT Margin (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Phathom Pharmaceuticals reported EBT Margin of -40.98%, up 248.42 percentage points year-over-year; for FY2025, it was -126.24%, up 478.84 percentage points from FY2024.
- Going back by year, EBT Margin was -605.08% in FY2024 (+28926.30 pp) and -29531.38% in FY2023.
- The Q2 2026 figure represents the highest quarterly EBT Margin in data going back to Q4 2023.
- Year-over-year, EBT Margin has increased for seven consecutive quarters, with an average year-over-year change of +2513.77 percentage points over the last seven quarters.
- Business Quant data shows PHAT's EBT Margin at -50.66% (Q1 2026), -36.72% (Q4 2025) and -60.53% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Phathom Pharmaceuticals | 588.51 Mn | -51.44 Mn | 59.18 Mn | -23.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.64% |
| Mar 31, 2026 | -50.66% |
| Dec 31, 2025 | -36.72% |
| Sep 30, 2025 | -60.53% |
| Jun 30, 2025 | -191.52% |
| Mar 31, 2025 | -330.64% |
| Dec 31, 2024 | -251.15% |
| Sep 30, 2024 | -523.29% |
| Jun 30, 2024 | -1,248.50% |
| Mar 31, 2024 | -4,331.01% |
| Dec 31, 2023 | -11,665.10% |
API Access
Phathom Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHAT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "PHAT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=PHAT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();